Subthalamic nucleus stimulation is efficacious in patients with Parkinsonism and LRRK2 mutations.
Schüpbach M, Lohmann E, Anheim M, Lesage S, Czernecki V, Yaici S, Worbe Y, Charles P, Welter ML, Pollak P, Dürr A, Agid Y, Brice A.
Schüpbach M, et al.
Mov Disord. 2007 Jan;22(1):119-22. doi: 10.1002/mds.21178.
Mov Disord. 2007.
PMID: 17080443
Clinical Trial.